StockNews.com Begins Coverage on Cutera (NASDAQ:CUTR)

StockNews.com assumed coverage on shares of Cutera (NASDAQ:CUTR) in a research report report published on Tuesday. The brokerage issued a sell rating on the medical device company’s stock.

Cutera Stock Performance

Shares of CUTR stock opened at $0.04 on Tuesday. Cutera has a 52-week low of $0.09 and a 52-week high of $2.70. The firm has a market capitalization of $787,254.00, a PE ratio of -0.01 and a beta of 1.36. The stock has a fifty day simple moving average of $0.04 and a two-hundred day simple moving average of $0.28.

Institutional Investors Weigh In On Cutera

A hedge fund recently raised its stake in Cutera stock. Geode Capital Management LLC boosted its holdings in Cutera, Inc. (NASDAQ:CUTR) by 25.2% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 248,257 shares of the medical device company’s stock after buying an additional 50,046 shares during the period. Geode Capital Management LLC owned 1.23% of Cutera worth $88,000 as of its most recent SEC filing. 90.70% of the stock is owned by institutional investors.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.